Literature DB >> 28492356

High-Frequency Irreversible Electroporation: Safety and Efficacy of Next-Generation Irreversible Electroporation Adjacent to Critical Hepatic Structures.

Imran A Siddiqui1, Russell C Kirks1, Eduardo L Latouche2, Matthew R DeWitt2, Jacob H Swet1, Erin H Baker1, Dionisios Vrochides1, David A Iannitti1, Rafael V Davalos2, Iain H McKillop1.   

Abstract

Irreversible electroporation (IRE) is a nonthermal ablation modality employed to induce in situ tissue-cell death. This study sought to evaluate the efficacy of a novel high-frequency IRE (H-FIRE) system to perform hepatic ablations across, or adjacent to, critical vascular and biliary structures. Using ultrasound guidance H-FIRE electrodes were placed across, or adjacent to, portal pedicels, hepatic veins, or the gall bladder in a porcine model. H-FIRE pulses were delivered (2250 V, 2-5-2 pulse configuration) in the absence of cardiac synchronization or intraoperative paralytics. Six hours after H-FIRE the liver was resected and analyzed. Nine ablations were performed in 3 separate experimental groups (major vessels straddled by electrodes, electrodes placed adjacent to major vessels, electrodes placed adjacent to gall bladder). Average ablation time was 290 ± 63 seconds. No electrocardiogram abnormalities or changes in vital signs were observed during H-FIRE. At necropsy, no vascular damage, coagulated-thermally desiccated blood vessels, or perforated biliary structures were noted. Histologically, H-FIRE demonstrated effective tissue ablation and uniform induction of apoptotic cell death in the parenchyma independent of vascular or biliary structure location. Detailed microscopic analysis revealed minor endothelial damage within areas subjected to H-FIRE, particularly in regions proximal to electrode insertion. These data indicate H-FIRE is a novel means to perform rapid, reproducible IRE in liver tissue while preserving gross vascular/biliary architecture. These characteristics raise the potential for long-term survival studies to test the viability of this technology toward clinical use to target tumors not amenable to thermal ablation or resection.

Entities:  

Keywords:  biomedical engineering; image-guided surgery; surgical oncology

Mesh:

Year:  2017        PMID: 28492356     DOI: 10.1177/1553350617692202

Source DB:  PubMed          Journal:  Surg Innov        ISSN: 1553-3506            Impact factor:   2.058


  7 in total

Review 1.  Novel ablation methods for treatment of gliomas.

Authors:  Brittanie Partridge; John H Rossmeisl; Alexandra M Kaloss; Erwin Kristobal Gudenschwager Basso; Michelle H Theus
Journal:  J Neurosci Methods       Date:  2020-02-14       Impact factor: 2.390

2.  The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro.

Authors:  Maria Scuderi; Matej Rebersek; Damijan Miklavcic; Janja Dermol-Cerne
Journal:  Radiol Oncol       Date:  2019-06-01       Impact factor: 2.991

3.  Hydrogen gas therapy induced shrinkage of metastatic gallbladder cancer: A case report.

Authors:  Ji-Bing Chen; Zhong-Bao Pan; Duan-Ming Du; Wei Qian; Yang-Yang Ma; Feng Mu; Ke-Cheng Xu
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

4.  Dynamics of Cell Death After Conventional IRE and H-FIRE Treatments.

Authors:  Borja Mercadal; Natalie Beitel-White; Kenneth N Aycock; Quim Castellví; Rafael V Davalos; Antoni Ivorra
Journal:  Ann Biomed Eng       Date:  2020-02-05       Impact factor: 3.934

Review 5.  A Review on Differences in Effects on Normal and Malignant Cells and Tissues to Electroporation-Based Therapies: A Focus on Calcium Electroporation.

Authors:  Stine K Frandsen; Julie Gehl
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

6.  Electroporation and cell killing by milli- to nanosecond pulses and avoiding neuromuscular stimulation in cancer ablation.

Authors:  Emily Gudvangen; Vitalii Kim; Vitalij Novickij; Federico Battista; Andrei G Pakhomov
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.996

Review 7.  Electrotherapies for Glioblastoma.

Authors:  Elise P W Jenkins; Alina Finch; Magda Gerigk; Iasonas F Triantis; Colin Watts; George G Malliaras
Journal:  Adv Sci (Weinh)       Date:  2021-07-22       Impact factor: 16.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.